Article Information
History
- November 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Akahito Sako, MD, MPH1,*,
- Yoshiaki Gu, MD, MPH, PhD2,
- Yoshinori Masui, MD1,
- Kensuke Yoshimura, MD, MPH, PhD3,
- Hidekatsu Yanai, MD, PhD1 and
- Norio Ohmagari, MD, MSc, PhD4
- 1Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, 1-7-1 Kohnodai, Ichikawa, Chiba, Japan
- 2Department of Infectious Diseases, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
- 3Center for Next Generation of Community Health, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, Japan
- 4Disease Control and Prevention Center, Center Hospital, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan
- ↵*Corresponding author:
Akahito Sako, Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, 1-7-1 Kohnodai, Ichikawa, Chiba 272-8516, Japan, Tel: +81-47-372-3501; Fax: +81-47-372-1858; E-mail: dsako{at}hospk.ncgm.go.jp
Posted November 17, 2022.
Prescription of anti-influenza drugs in Japan, 2014-2020: a retrospective study using open data from the national claims database
